- Device
- Vivistim® System
- Applicant
- Mobia Medical, Inc.
- PMA number
- P210007
- Supplement
- S002
- Product code
- QPY
- Generic name
- Stimulator, autonomic nerve, implanted for stroke rehabilitation
- Decision date
- 2024-03-25
- Decision code
- APPR
- Date received
- 2024-01-23
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Approval order statement
- The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for modifications to device labeling. Based upon the information submitted, the PMA supplement is approved.